Corning Announces New Advanced Life Sciences Research, Collaboration and Education Center

We use cookies to ensure the best experience on our website.
View Cookie Policy
Accept Cookie Policy
Change My Settings
Required for the site to function.
Augment your site experience.
Lets Corning work with partners to enable social features and marketing messages.

Esta página possui melhor visualização com última versão do Google Chrome e do Mozilla Firefox.

Image Alt Text

Corning Announces New Advanced Life Sciences Research, Collaboration and Education Center

Corning Announces New Advanced Life Sciences Resea

News Releases
Corning Announces New Advanced Life Sciences Research, Collaboration and Education Center
Corning Announces New Advanced Life Sciences Research, Collaboration and Education Center
CORNING, N.Y. | Corning Incorporated | July 13, 2012
Lab to support West Coast industry and academia, showcase full range of Corning Life Sciences’ offerings

Corning Life Sciences, a segment of Corning Incorporated (NYSE: GLW), today announced the opening of a life sciences lab in Palo Alto, Calif. The new lab is housed within the existing Corning West Technology Center and will further expand Corning’s customer- and research-centric approach to developing leading products and technologies for the life sciences industry.

This newest Corning innovation lab offers customers and researchers from across industry and academia the life sciences solutions and onsite expertise needed to conduct successful cell-based, biochemical, and molecular biology assays. The new lab will help scientists improve research methods and results through collaborations, educational demonstrations, and tutorials. Since construction was completed in early May, the lab has hosted many leading West Coast biotech, chemical, and pharmaceutical companies, as well as academic institutions, including Stanford University.

“The Corning® Epic® technology, with its label-free and dynamic mass redistribution characterization capabilities, and local support from Corning’s new lab that helped get the experiments up and running, have been absolutely invaluable in our study of orphan G-protein receptors,” said Calvin Kuo, M.D., Ph.D., professor of medicine, Division of Hematology, Stanford University School of Medicine.

The lab is equipped with a full range of Corning’s advanced life sciences products and technologies, including a prototype of next generation Corning® Epic® technology. The lab and its staff will work closely with Corning’s other research and technical facilities, including the Axygen Automation Lab in Union City, Calif. Both labs will further engage customers, collaborate on next-generation life sciences research, and incorporate industry feedback into the Corning Life Sciences R&D portfolio.

The Axygen Automation Laboratory was established in 2011 to provide end users with firsthand experience with automation labware consumables made by Corning and its subsidiaries. The lab has been instrumental in furthering research results and product development efforts in the areas of genomics, Next Generation Sequencing, and lab automation.

The Corning West Technology Center (CWTC) was established in 2007 in Silicon Valley as a research and new-business-development hub interacting with industry, academia, and the venture capital and startup communities on the West Coast. CWTC, a unit of Corning’s Science and Technology Division, is staffed with scientists and engineers working on state-of-the-art applied research in touch technologies, high-speed fiber-optic interconnects, and advanced solid-state illumination packaging techniques.

“We are pleased to offer our customers, specifically those on the West Coast, with an additional technology resource for their life sciences research,” said Dr. Richard Eglen, vice president and general manager, Corning Life Sciences. “Innovation, R&D, and working closely with our customers are central to our business and the new lab is a testament to that commitment. We are excited about the potential this lab has for both Corning and our customers as we work together to identify new challenges and opportunities, develop new technologies, and advance research findings for greater benefit far beyond the laboratory walls.”

Through acquisition and internal R&D investment, Corning now offers a more comprehensive range of premium, innovative laboratory products and solutions for a wide spectrum of life science applications. Corning’s trusted, quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of the process to the end. The family of brands includes Corning®, PYREX®, Costar®, Axygen®, Gosselin™ and Corning cellgro®.

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

To learn more about any Corning Life Sciences product, please contact a customer service representative at 1-800-492-1110, toll free in the United States, (+1) 1-978-442-2200 internationally, or visit .

Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About Corning Incorporated
Corning Incorporated ( ) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.